Basic Information


GTO ID GTC1316
Trial ID NCT00890032
Disease Central Nervous System Neoplasm
TherapymRNA vaccine
Treatment BTSC mRNA-loaded DCs
PhasePhase1
Recruitment statusCompleted
TitleRecurrent GBM Stem Cell Tumor Amplified RNA Immunotherapy Trial
Year2009
CountryUnited States
Company sponsorJohn Sampson
Other ID(s)Pro00006677|R01CA135272|P30CA014236|CDR0000630701
Vector information
Vectordendritic cell

Clinical Result

Cohort1: dose level 1
Administration route intradermal injection
Dosage 2E6 cells
Age Adult, Older_Adult
Cohort2: dose level 2
Administration route intradermal injection
Dosage 5E6 cells
Age Adult, Older_Adult
Cohort3: dose level 3
Administration route intradermal injection
Dosage 2E7 cells
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph